SCHEMBL9234881

SCHEMBL9234881

Oc1ccc2c(O)c(Br)ccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 8/20 0.43
▸ ESR2 Q92731 8/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ LMNA P02545 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ ALOX15 P16050 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ TSHR P16473 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ HSD17B1 P14061 2/20 0.40
▸ HSD17B2 P37059 2/20 0.40
▸ ABL1 P00519 1/20 0.38
▸ ABCB1 P08183 1/20 0.38
▸ BCR P11274 1/20 0.38
▸ ESRRB O95718 1/20 0.37
▸ ESRRA P11474 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29683574 1.00 ESR1 (0.43) ESR1ESR2CYP1A2LMNAMEN1
SCHEMBL28668196 0.84 ESR1 (0.42) ESR1ESR2CYP1A2LMNAALOX15
SCHEMBL28982382 0.83 ERN1 (0.50) LMNAMEN1POLBKMT2AALOX15
SCHEMBL23155056 0.79 AR (0.41) ESR1ESR2MEN1KMT2AALOX15
SCHEMBL31590230 0.79 AR (0.41) ESR1ESR2MEN1KMT2AALOX15
SCHEMBL1533447 0.78 CYP1A2 (0.57) ESR1ESR2CYP1A2LMNAMEN1
SCHEMBL29720904 0.77 PTPN22 (0.54) ESR1ESR2CYP1A2ALOX15HSD17B10
SCHEMBL3213734 0.77 PTPN22 (0.54) ESR1ESR2CYP1A2ALOX15HSD17B10
SCHEMBL29899643 0.76 CYP1A2 (0.55) ESR1ESR2CYP1A2LMNAMEN1
SCHEMBL1692369 0.76 CYP1A2 (0.55) ESR1ESR2CYP1A2LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114656467-B Organic compounds, mixtures, compositions and organic electronic devices 广州华睿光电材料有限公司 2024-06-25 — — CN disclosed
EP-3265447-B1 BENZOXAZINE LOW TEMPERATURE CURABLE COMPOSITION HUNTSMAN ADVANCED MAT AMERICAS LLC (US) 2023-03-01 — — EP disclosed
CN-114656467-A Organic compound, mixture, composition and organic electronic device 广州华睿光电材料有限公司 2022-06-24 — — CN disclosed
US-11247905-B2 Synthesis of graphene nanoribbons from monomeric molecular precursors bearing reactive alkyne moieties THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-02-15 — — US disclosed
US-20200055735-A1 SYNTHESIS OF GRAPHENE NANORIBBONS FROM MONOMERIC MOLECULAR PRECURSORS BEARING REACTIVE ALKYNE MOIETIES UNIV CALIFORNIA (US) 2020-02-20 — — US disclosed
US-20180030264-A1 Benzoxazine Low Temperature Curable Composition HUNTSMAN ADVANCED MATERIALS AMERICAS LLC 2018-02-01 — — US disclosed
EP-0661322-A2 Modified polyepoxy compound, process for producing the compound, and epoxy resin composition SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1995-07-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180030264-A1 Benzoxazine Low Temperature Curable Composition CRYZ, PIEZO1, PSMD12 ESR1 171/4885ESR2 858/4885CYP1A2 1337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback